Endometrial and Cervical Cancer Treatments
Endometrial and Cervical Cancer Treatments is a research topic within Obstetrics and Gynecology. Science Explorer counts 41k research works in it since 1950. 16.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers encompasses a wide range of research on gynecologic oncology, including advancements in the understanding and treatment of endometrial carcinoma and cervical cancer. Topics covered include molecular classification, radiation therapy techniques such as brachytherapy, the role of sentinel lymph node biopsy, the efficacy of chemoradiotherapy, advancements in robotic surgery, and survival analysis. The cluster also includes discussions on clinical practice guidelines for the management of gynecologic cancers.
- Endometrial Carcinoma
- Cervical Cancer
- Brachytherapy
- Radiation Therapy
- Molecular Classification
- Sentinel Lymph Node Biopsy
- Chemoradiotherapy
- Robotic Surgery
- Survival Analysis
- Clinical Practice Guidelines
- Research works
- 41k fractional, since 1950
- In the world top 10%
- 6.8k per year above
- Top-10% rate
- 16.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +30% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Endometrial and Cervical Cancer Treatments research?
By volume, China and the United States publish the most (1.8k and 1.6k works in 2022–2025).
By volume, 2022–2025
- 1 China 1.8k works
- 2 United States 1.6k works
- 3 India 510 works
- 4 Italy 438 works
- 5 Japan 424 works
- 6 South Korea 265 works
- 7 United Kingdom 264 works
- 8 Türkiye 255 works
- 9 Germany 241 works
- 10 Spain 232 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Endometrial and Cervical Cancer Treatments research?
By volume in 2022–2025, Memorial Sloan Kettering Cancer Center publishes the most Endometrial and Cervical Cancer Treatments research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Agostino Gemelli University Polyclinic.
By volume, 2022–2025
- 1 Memorial Sloan Kettering Cancer CenterUnited States 55 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 52 works
- 3 Agostino Gemelli University PolyclinicItaly 51 works
- 4 Obstetrics and Gynecology Hospital of Fudan UniversityChina 47 works
- 5 The University of Texas MD Anderson Cancer CenterUnited States 46 works
- 6 Sichuan UniversityChina 35 works
- 7 Peking UniversityChina 34 works
- 8 Istituti di Ricovero e Cura a Carattere ScientificoItaly 33 works
- 9 Fujian Medical UniversityChina 31 works
- 10 Peking Union Medical College HospitalChina 28 works
Who are the leading researchers in Endometrial and Cervical Cancer Treatments?
The most-cited researchers publishing on Endometrial and Cervical Cancer Treatments include Elisabete Weiderpass and Gordon B. Mills.
- 1 Elisabete Weiderpass France 6k citations
- 2 Gordon B. Mills United States 3.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Endometrial and Cervical Cancer Treatments research done?
The largest centres of Endometrial and Cervical Cancer Treatments research in 2022–2025 are Beijing (China), Seoul (South Korea), Shanghai (China) and New York (United States).
Where is the best place to study Endometrial and Cervical Cancer Treatments?
Among universities, judged by research, Kagoshima University, Chinese Academy of Medical Sciences & Peking Union Medical College and Università Cattolica del Sacro Cuore score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Kagoshima UniversityJapan | 67.4 | 32.7% | 13.9× | 12 | +187.2% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 65.5 | 23.7% | 6.7× | 52 | +148.5% |
| 3 | Università Cattolica del Sacro CuoreItaly | 63.8 | 29.8% | 11.4× | 26 | +3.6% |
| 4 | Medical University of LublinPoland | 59.2 | 42.9% | 6.8× | 9 | +124.8% |
| 5 | Carol Davila University of Medicine and PharmacyRomania | 58.4 | 18.2% | 9.8× | 13 | +442.1% |
| 6 | China Medical UniversityChina | 57.3 | 30.1% | 9.0× | 24 | -17.1% |
| 7 | Fujian Medical UniversityChina | 53.2 | 15.6% | 10.9× | 31 | -7.2% |
| 8 | Cornell UniversityUnited States | 50.4 | 36.3% | 2.6× | 22 | +65.2% |
| 9 | University of British ColumbiaCanada | 46.4 | 28.3% | 2.4× | 20 | +94.9% |
| 10 | Dalian Medical UniversityChina | 43.5 | 20.7% | 8.1× | 12 | +15.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Endometrial and Cervical Cancer Treatments research growing?
Output in 2018–2022 was 30% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Endometrial and Cervical Cancer Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.